Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc. Ushering in a new era for treating diseases with high unmet needs

Wolfram syndrome is a rare, monogenic neurodegenerative disease that progressively impacts multiple organs and systems. ...
09/03/2025

Wolfram syndrome is a rare, monogenic neurodegenerative disease that progressively impacts multiple organs and systems. There are currently no approved therapies for the approximately 3,000 people in the U.S. living with . Learn more on our website at https://amylyx.com

08/27/2025

Today, we announced the decision to discontinue the ORION program for progressive supranuclear palsy.

We extend our gratitude to the participants, their families and care partners, ORION trial sites, and the entire PSP community for their collaboration on this study. We remain committed to advancing potential new treatments for communities with high unmet needs.

Read more in our press release: https://bit.ly/4fZDl2v

08/21/2025

What we’re doing, why, and how we’re doing it is deeply interwoven. Learn more about each of the core values guiding below.

Firsthand experiences of community members motivate our work, because shifting the trajectory of diseases with high unme...
08/19/2025

Firsthand experiences of community members motivate our work, because shifting the trajectory of diseases with high unmet needs first requires learning what changes will make meaningful differences for those most impacted.

Jessica is a passionate mother, case manager, and advocate with post-bariatric (PBH). She shared her story – and unwavering determination – with us to raise : https://www.amylyx.com/jessicas-PBH-story

We have an audacious mission to develop novel therapies for high unmet needs. Where others see challenges, we see opport...
08/14/2025

We have an audacious mission to develop novel therapies for high unmet needs. Where others see challenges, we see opportunities that members of like Joe Wong pursue with urgency and unwavering commitment to the communities we serve. Learn more: https://amylyx.com/our-company

ALS affects as many as 30,000 adults in the U.S. and 3,000 in Canada. The most common form of the disease is sporadic ,...
08/05/2025

ALS affects as many as 30,000 adults in the U.S. and 3,000 in Canada. The most common form of the disease is sporadic , with more than 90% of people with ALS showing no clear family history. Learn more on our website at https://amylyx.com

07/31/2025

Maggie recently shared with us that post-bariatric hypoglycemia, or PBH, controls everything in her life.

She’s one of ~160,000 people estimated to be living with this condition in the U.S., and like too many others, Maggie has experienced debilitating symptoms of PBH.

We’re grateful that Maggie chose to share her story so that we can help raise awareness of PBH and counter some of the misconceptions that are out there about this condition. Watch the full video on our website: https://www.amylyx.com/community

Staying true to our purpose and commitment would not be possible without each individual perspective within our talented...
07/24/2025

Staying true to our purpose and commitment would not be possible without each individual perspective within our talented team. We’re made up of determined, passionate, and empathetic people, like Katrina Carey. Learn more about Amylyx’ mission and history: https://www.amylyx.com/our-company

Imagine living with a condition that has debilitating symptoms and has no approved treatments. Have you heard of PBH?Pos...
07/22/2025

Imagine living with a condition that has debilitating symptoms and has no approved treatments. Have you heard of PBH?

Post-bariatric hypoglycemia (PBH) is a condition that can occur after metabolic and bariatric surgery and causes sharp blood sugar swings that can lead to a wide range of symptoms. Over time, repeated episodes may lead to hypoglycemia unawareness, where warnings signs of low blood sugar disappear until your levels drop dangerously low. Because of this, many people with PBH are unable to work, drive, be alone, or care for themselves or others.

While there are no approved therapies, there is important research being done to understand, diagnose, and treat PBH. We partnered with those affected to create the “Understanding PBH” guide to help provide trusted education and support. Explore and share to help raise awareness and remind others they’re not alone. https://bit.ly/4ii1Qr1

left with new connections and great insights to guide our work in endocrine conditions like post-bariatric hypoglyce...
07/18/2025

left with new connections and great insights to guide our work in endocrine conditions like post-bariatric hypoglycemia ( ). Check out some highlights from the conference below.

Amylyx’ head of patient advocacy Irene Aquino will be participating in a panel at the 5th Chief Patient Officer Summit i...
07/17/2025

Amylyx’ head of patient advocacy Irene Aquino will be participating in a panel at the 5th Chief Patient Officer Summit in Boston next week. She and her fellow panelists are discussing how to align corporate affairs and communications with patient advocacy to drive real impact, and we can’t wait to hear what insights she brings back to our organization.

Address

Cambridge, MA

Website

https://www.amylyx.com/social-media-guidelines

Alerts

Be the first to know and let us send you an email when Amylyx Pharmaceuticals Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Amylyx Pharmaceuticals Inc.:

Shortcuts

Share